< Back to search
Filter
1

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

for
Brain Cancer, Glioblastoma, Metastatic Cancer,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06058988

Phase2, Recruiting

Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

for
Glioblastoma Multiforme, Relapse
Location: Sherbrooke
Sponsor: Université de Sherbrooke

Sex: All

Age: 18+

Code: NCT06356883

Phase2, Recruiting

Study of Letrozole in Recurrent Gliomas

for
Brain Tumor
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT03122197

Early_phase1, Recruiting

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

for
Glioblastoma Multiforme
Location: Durham NC, Detroit MI, Chicago IL, Dallas TX,
Sponsor: Novacea

Sex: All

Age: 18+

Code: NCT00394628

Phase1, Phase2, Recruiting

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

for
Glioblastoma Multiforme, Anaplastic Astrocytoma
Location: New York NY
Sponsor: Northwell Health

Sex: All

Age: 18+

Code: NCT01269853

Phase1, Phase2, Recruiting

Interested in new malignant glioma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

for
Primary Brain Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 19+

Code: NCT03830151

Phase1, Recruiting

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

for
High Grade Astrocytic Tumor,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05465954

Phase2, Recruiting

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

for
Glioblastoma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05917145

Phase1, Recruiting

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

for
Glioblastoma Multiforme
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT05083754

Phase1, Recruiting

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

for
Glioblastoma (GBM)
Location: Boston MA, New York NY, Summit NJ, New Brunswick NJ,
Sponsor: Diakonos Oncology Corporation

Sex: All

Age: 18+

Code: NCT06805305

Phase2, Recruiting

Evaluation of the CONVIVO System

for
Glioblastoma, Glial Tumor, Brain Metastases, Meningioma,
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18+

Code: NCT05139277

Recruiting

Sonodynamic Therapy in Patients With Recurrent GBM

for
Recurrent Glioblastoma, Glioblastoma Multiforme, GBM
Location: Charlottesville VA
Sponsor: Shayan Moosa, MD

Sex: All

Age: 18 - 70+

Code: NCT06039709

Phase1, Recruiting

Loupe-Based Intraoperative Fluorescence Imaging

for
Glioblastoma Multiforme, Anaplastic Astrocytoma
Location: Lexington KY
Sponsor: Guoqiang Yu

Sex: All

Age: 18 - 70+

Code: NCT04780009

Recruiting

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

for
Glioblastoma, Recurrent Glioblastoma,
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06613841

Early_phase1, Recruiting

Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

for
Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT04991870

Phase1, Recruiting

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

for
Solid Tumors, Advanced Cancer, Renal Cancer, Gastric Cancer,
Location: Montreal, Hershey PA, Chapel Hill NC, Toronto,
Sponsor: Apollomics Inc.

Sex: All

Age: 18+

Code: NCT03175224

Phase2, Recruiting

The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma

for
IDH-Wildtype Glioblastoma, Glioblastoma (GBM)
Location: Ottawa, London
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06850766

Recruiting

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

for
Glioblastoma Multiforme, Recurrent Glioblastoma
Location: New York NY, Jacksonville FL, Chicago IL, St Louis MO,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT05303467

Phase1, Recruiting

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

for
Glioblastoma Multiforme
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05864976

Recruiting

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

for
Malignant Brain Neoplasm, Malignant Glioma
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT03510208

Phase1, Phase2, Recruiting